Allergy Relief Capsule, Liquid Filled
NDC 70000-0755
Product Information
Allergy Relief (loratadine) is a ANDA-approved product labeled by Cardinal Health 110, Llc. Dba Leader. Diphenhydramine is an antihistamine used to relieve symptoms of allergy, hay fever, and the common cold. It is supplied as a blue capsule, liquid filled for oral administration. This product entry covers the primary NDC 70000-0755 and its associated package configuration. This profile includes active and inactive ingredient UNII references and FDA labeling data.
Primary Identification
Clinical Specifications
Labeler & Regulatory Data
Marketing Timeline
Product Characteristics
21
Code Structure Chart
Product Details
What is NDC 70000-0755?
What are the uses of this product?
What are Active Ingredients of this product?
- LORATADINE 10 mg/1 - A second-generation histamine H1 receptor antagonist used in the treatment of allergic rhinitis and urticaria. Unlike most classical antihistamines (HISTAMINE H1 ANTAGONISTS) it lacks central nervous system depressing effects such as drowsiness.
Which are the associated UNII Codes?
The UNII codes for the active ingredients in this product are:
- LORATADINE (UNII: 7AJO3BO7QN)
- LORATADINE (UNII: 7AJO3BO7QN) (Active Moiety)
Which are the Inactive Ingredients associated UNII Codes?
The inactive ingredients are all the component of a medicinal product OTHER than the active ingredient(s). The acronym "UNII" stands for “Unique Ingredient Identifier” and is used to identify each inactive ingredient present in a product. The UNII codes for the inactive ingredients in this product are:
- CAPRIC ACID (UNII: 4G9EDB6V73)
- POVIDONE K30 (UNII: U725QWY32X)
- WATER (UNII: 059QF0KO0R)
- SORBITOL (UNII: 506T60A25R)
- POLYSORBATE 80 (UNII: 6OZP39ZG8H)
- SORBITAN (UNII: 6O92ICV9RU)
- FD&C BLUE NO. 1 (UNII: H3R47K3TBD)
- GELATIN (UNII: 2G86QN327L)
What is the NDC to RxNorm Crosswalk for this product?
- RxCUI: 828269 - loratadine 10 MG 24HR Oral Capsule
- RxCUI: 828269 - loratadine 10 MG Oral Capsule
* Please review the full disclaimer at the bottom of this page.